The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).
 
Shannon L. Maude
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
George E Hucks
No Relationships to Disclose
 
Alix Eden Seif
No Relationships to Disclose
 
Mala Kiran Talekar
No Relationships to Disclose
 
David T. Teachey
Consulting or Advisory Role - Janssen
Research Funding - Novartis (Inst)
 
Diane Baniewicz
No Relationships to Disclose
 
Colleen Callahan
No Relationships to Disclose
 
Vanessa Gonzalez
Research Funding - Novartis
 
Farzana Nazimuddin
No Relationships to Disclose
 
Minnal Gupta
Research Funding - Novartis
 
Noelle V. Frey
Consulting or Advisory Role - Amgen
Research Funding - Novartis
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech/Roche (I)
Honoraria - Incyte
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
Travel, Accommodations, Expenses - Immunovative Therapies
 
Bruce L Levine
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc.
Honoraria - Novartis
Consulting or Advisory Role - GE Healthcare
Research Funding - Novartis; Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - intellectual property and patents in the field of cell and gene therapy
Travel, Accommodations, Expenses - GE Healthcare
 
Jan J. Melenhorst
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent related to the manufacturing of CART cells and biomarkers in CART cell therapy
 
Simon F. Lacey
Research Funding - Novartis
 
Carl H. June
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Celldex; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties
 
Stephan A. Grupp
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis